Last $100.30 USD
Change Today -0.81 / -0.80%
Volume 11.5M
GILD On Other Exchanges
As of 5:20 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Norbert W. Bischofberger Ph.D.

Chief Scientific Officer and Executive Vice President of Research & Development, Gilead Sciences Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2013


Dr. Norbert W. Bischofberger, Ph.D, has been the Chief Scientific Officer of Gilead Sciences Inc. since March 9, 2007 and has been its Executive Vice President, Research and Development since November 2000. Dr. Bischofberger joined Gilead in 1990 as Director of Organic Chemistry and served as its Vice President of Organic Chemistry since February 1993 and Vice President of Research since August 1995. Dr. Bischofberger served as Senior Vice President Research at Gilead ...

Read Full Background

Corporate Headquarters*

333 Lakeside Drive
Foster City, California 94404

United States

Phone: 650-574-3000
Fax: 650-578-9264

Board Members Memberships*

There is no Board Members Memberships data available.


Post-Doctoral Training
Harvard University
Universität Innsbruck
Eidgenössische Technische Hochschule Zürich

Other Affiliations*

Annual Compensation*

Total Annual Compensation$884,175

Stock Options*

Restricted Stock Awards$1,740,781
All Other Compensation$95,378
Exercised Options540,000
Exercised Options Value$26,581,041
Exercisable Options1,603,824
Exercisable Options Value$89,513,601
Unexercisable Options383,736
Unexercisable Options Value$17,716,695
Total Value of Options$133,811,337
Total Number of Options2,527,560

Total Compensation*

Total Annual Cash Compensation$2,047,553
Total Short Term Compensation$884,175
Other Long Term Compensation$1,836,159
Total Calculated Compensation$5,588,388
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GILD:US $100.30 USD -0.81


Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GILEAD SCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at